Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
DIR DL S&P BIO BULL (NY: LABU)
86.79 USD  -5.36 (-5.82%)
Official Closing Price  /  Updated: 8:04 PM EDT, May 21, 2018  /  Add to My Watchlist      
View: Quote News
Fund Overview
DIR DL S&P BIO BULL
Sector
Exchange Traded NY
Net Assets 374.20M
Inception Date
Related Funds SPYD VDU AGGY IXP
Quote
Price 86.79
Volume 1,439,180
Last Trade May 21, 8:04pm
Change (%)
-5.36 (-5.82%)
Prev. Close 92.15
YTD %
+3.21%
Dividend Yield 0.15%
Performance
YTD
+2.70 (3.21%)
1 Month
+6.44 (8.01%)
3 Month
-3.69 (-4.08%)
6 Month
+18.30 (26.72%)
1 Year
+39.41 (83.18%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Best & Worst Weekly Performers: May 19 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Best & Worst Weekly Performers: May 12 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Top News
More News
Daily S&P Biotech Bull 3X Shares (LABU) Shares Cross Above 200 DMA
In trading on Wednesday, shares of the Daily S&P Biotech Bull 3X Shares ETF (LABU) crossed above their 200 day moving average of $80.10, changing hands as high as $83.08 per share. Daily S&P Biotech... Read More
from ETF Channel
The Week Ahead: Nvidia And Dropbox Earnings, April Retail Sales, Trump Drug Pricing Speech Expected
Below is a list of notable corporate events for the week beginning May 7. Note, this list is not comprehensive and all dates are subject ... Read More
from Benzinga
Best & Worst Weekly Performers: May 5 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Buy on the Dip Prospects: April 23 Edition
Below is a look at ETFs that currently offer attractive buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be in... Read More
from ETFdb
As The Market Scrambles Over Tech And Trade Fears, ETF Fund Flow Signals Interesting Rotation
Fear continues to grip traders and investors in a wrestling match between a market filled with fundamental promise and a global and ... Read More
from Benzinga
Big Biotech ETF Can Bounce Back
The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund by assets, and other biotechnology assets have recently been slumping, but some analysts believe big... Read More
from ETF Trends
Best & Worst Weekly Performers: April 14 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
LABU: ETF Inflow Alert
Symbols mentioned in this story: LABU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded... Read More
from ETF Channel
LABU Makes Bullish Cross Above Critical Moving Average
In trading on Tuesday, shares of the Daily S&P Biotech Bull 3X Shares ETF (LABU) crossed above their 200 day moving average of $78.85, changing hands as high as $79.59 per share. Daily S&P Biotech Bull... Read More
from ETF Channel
Catalysts Abound for Biotech ETFs
Biotechnology stocks and biotech ETFs tumbled in the back half of March and to start April. For example, the SPDR S&P Biotech ETF (NYSEArca: XBI) came into Monday with a loss of almost 12.6% over the... Read More
from ETF Trends
Best & Worst Weekly Performers: April 7 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Best & Worst Weekly Performers: March 31 Edition
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
For Now, Traders Endorse Biotech Rally
Among leveraged and inverse biotechnology exchange-traded funds, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) and the ... Read More
from Benzinga
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial